Subsequent Disclosure. If the Codexis Alliance Manager requests further information regarding Arising GSK Enzyme Technology and/or Arising GSK Process Technology, Codexis shall, within [***] days after receipt of the initial disclosure of such Arising GSK Enzyme Technology and/or such Arising GSK Process Technology by GSK pursuant to Section 2.2.10(a) request the disclosure of such further information Controlled by GSK.
Appears in 2 contracts
Sources: Platform Technology Transfer, Collaboration and License Agreement (Codexis, Inc.), Platform Technology Transfer, Collaboration and License Agreement (Codexis Inc)